Gram-negative Bacterial Infection
📧 Sign up to get email alerts when something new happens for Gram-negative Bacterial Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH) [Phase 2]
Phase 2 CHERISH study to evaluate Aztreonam-Avibactam (ATM-AVI) for Gram-negative bacterial infections in hospitalized infants and newborns;…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST) [NA]
A recruiting clinical trial evaluating how rapid antimicrobial susceptibility testing tools influence antibiotic stewardship and patient out…
-
EMA approval · 2025-11-21EMA Authorised: Invanz (ertapenem sodium) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Invanz (ertapenem sodium) by Merck Sharp & Dohme B.V. for a range of infections including community…
-
CLINICAL_TRIALS withdrawal · 2024-09-04Clinical Trial Update: Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections [Phase 4]
A Phase 4 trial evaluating Imipenem/Cilastatin/Relebactam for carbapenem-resistant Enterobacteriaceae infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. [Phase 2]
Phase 2 trial update evaluating pharmacokinetics, safety, and tolerability of ceftazidime-avibactam in neonates and infants; study terminate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) [Phase 1]
A Phase 1 pharmacokinetics study of MK-7655A in pediatric participants with suspected or documented Gram-negative bacterial infections has c…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria [Phase 1]
This Phase 1 population pharmacokinetic study evaluates Colistin in patients infected with multidrug-resistant Gram-negative bacteria.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial [Phase 3]
A Phase 3 randomized trial evaluated whether Polymyxin B protects against sepsis-induced kidney dysfunction; results were posted in 2010.